Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Devic's Neuromyelitis Optica”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT07592754
What this trial is testing

The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)
Chinese PLA General Hospital 18
Testing effectiveness (Phase 2)UnknownNCT06557174
What this trial is testing

Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. 116
Testing effectiveness (Phase 2)UnknownNCT06497374
What this trial is testing

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 63
Testing effectiveness (Phase 2)UnknownNCT04064944
What this trial is testing

Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Third Affiliated Hospital, Sun Yat-Sen University 144
Post-approval studies (Phase 4)Study completedNCT04256252
What this trial is testing

Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 108
Not applicableLooking for participantsNCT06885957
What this trial is testing

Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

Who this might be right for
NMO Spectrum Disorder
Tongji Hospital 200
Not applicableEnrolling By InvitationNCT06374264
What this trial is testing

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
MedRhythms, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT05909943
What this trial is testing

Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Relapse
Tianjin Medical University General Hospital
Not applicableUnknownNCT04101058
What this trial is testing

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Third Affiliated Hospital, Sun Yat-Sen University 200
Very early researchNot Yet RecruitingNCT07392528
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMultiple SclerosisMyasthenia Gravis
Tianjin Huanhu Hospital 15
Early research (Phase 1)WithdrawnNCT06869278
What this trial is testing

LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Large-scale testing (Phase 3)Study completedNCT03002038
What this trial is testing

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Isfahan University of Medical Sciences 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT06044350
What this trial is testing

A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Optic Neuromyelitis Spectrum Disease
Bio-Thera Solutions 162
Not applicableLooking for participantsNCT06829524
What this trial is testing

HANDLE-a Real World Study on Satralizumab in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Huashan Hospital 100
Not applicableStudy completedNCT05871658
What this trial is testing

Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol

Who this might be right for
Neuromyelitis Optica Spectrum DisordersPain
Yuanqi Zhao,MD 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07818356
What this trial is testing

Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

Who this might be right for
VaccineVaricella-zoster VirusMultiple Sclerosis+1 more
University Hospital, Toulouse 160
Not applicableLooking for participantsNCT05909761
What this trial is testing

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Who this might be right for
Neuromyelitis Optica Spectrum DisorderPregnancy Related
Amgen 60
Post-approval studies (Phase 4)UnknownNCT02021825
What this trial is testing

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorders
Xuanwu Hospital, Beijing 50
Not applicableUnknownNCT01024985
What this trial is testing

Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
University of Sao Paulo 40
Not applicableUnknownNCT05414487
What this trial is testing

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisorderDemyelinating Diseases of the Central Nervous System
Tianjin Medical University General Hospital 34
Next Page